Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T06:11:22.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.1 to v3.4.2, which is a minor maintenance change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T13:37:11.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. No visible changes to study content.
    Difference
    0.0%
    Check dated 2026-02-06T09:16:10.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page, a non-functional metadata update that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T10:36:41.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    A centralized Locations section is added with state subsections for California, Florida, North Carolina, Pennsylvania, and Texas. The previous standalone state location blocks and the HHS Vulnerability Disclosure link are removed.
    Difference
    0.6%
    Check dated 2025-12-17T19:48:01.000Z thumbnail image
  8. Check
    107 days ago
    Change Detected
    Summary
    Publications section updated to indicate that PubMed publications are automatically filled and may not be about the study. The page revision now shows 'Revision: v3.3.2' and the previous wording with 'Revision: v3.2.0' was removed.
    Difference
    0.1%
    Check dated 2025-11-26T13:56:53.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.